// App-Quantinova.ai

PD2-01 : Clinically dormant ER+ breast tumors exhibit AMPK activation

Researchers

Presenter

  • RA Hampsch

Principal Investigators

  • LM Dillon

  • TW Miller

Medical Centers

  • Dartmouth College, Lebanon, NH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Estrogen resistance

  • Breast cancer

  • Diabetes

  • Solid malignancies

Biomarkers

  • AMP-activated protein kinase

  • Sequestosome-1

Drug/Treatment

  • Hydroxychloroquine

  • Fulvestrant

  • Alora

  • Metformin Hydrochloride

  • Estrogens

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved